This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The goal of the BICATOR trial was to determine whether treatment with low to moderate dose atorvastatin is associated with progression of ascending aortic dilation, valvular dysfunction, or valve calcification in patients with bicuspidaorticvalve.
What are the procedural and clinical outcomes of balloon-expandable valves (BEVs) and self-expanding valves (SEVs) in Sievers type 1 bicuspidaorticvalve (BAV) stenosis?
Douglas Weaver MD, MACC discuss the history of and complications associated with bicuspid valvuloaortopathy. In this interview, Hector I. Michelena, MD, FACC and W.
Patients with bicuspidaorticvalves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aorticvalve replacement (TAVR) versus surgical aorticvalve replacement (SAVR) in patients with BAV.
A 76-year-old woman with a history of double valve replacement (Aortic and mitralvalves) for rheumatic heart disease, presented with acute dyspnea after a switch from Warfarin to LMWH before a planned bone marrow biopsy. Balloon “Valvuloplasty” for Mechanical Valve Dysfunction. Ref3) Reference 1.
This technique is now employed in approximately 85% of all isolated aorticvalve replacements. In the past decade, the U.S. has seen a 25-fold increase in the use of TAVR, with more than 100,000 performed annually. Despite this growth, there are notable gaps in the evidence.
Is there a relationship between site-level volumes and outcomes for transcatheter aorticvalve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER)?
My patient is 59 years old, has symptomatic severe aortic stenosis (AS) with a bicuspidaorticvalve (BAV), and his proximal aorta is 3.6 He has no important comorbidities and was referred for advice as to whether he should have a surgical (SAVR) or transcatheter (TAVR) aorticvalve replacement.
While left ventricular (LV) systolic function is preserved, right ventricular dysfunction (RVD) and consecutive LV underfilling may contribute to low-flow and reduced stroke volume index, and to adverse outcomes following transcatheter aorticvalve implantation (TAVI).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content